Hepatitis B Surface Antigen Seroclearance Rate After Stopping Nucleos(t)ide Analogues in Chronic Hepatitis B—A Systematic Review and Meta‐Analysis

Documents similaires

• MRI for hepatocellular carcinoma and the role of abbreviated MRI for surveillance of hepatocellular carcinoma
  par: Soe Thiha Maung, et autres
  Publié: (2024)
• Scoping Review on Strategies for Safe Nucleot(s)ide Analogue Discontinuation and Optimising Functional Cure in Chronic Hepatitis B
  par: Soe Thiha Maung, et autres
  Publié: (2025)
• Diagnostic and Prognostic Performance of the Agile 3+ Score in Patients With Chronic Hepatitis B and Concurrent MASLD After Complete Viral Suppression With Nucleos(t)ide Analogues
  par: Hongsheng Yu, et autres
  Publié: (2025)
• Response to the Letter Regarding “Diagnostic and Prognostic Performance of the Agile 3+ Score in Patients With Chronic Hepatitis B and Concurrent MASLD After Complete Viral Suppression With Nucleos(t)ide Analogues”
  par: Hongsheng Yu, et autres
  Publié: (2026)
• Screening for viral hepatitis B infection in cancer patients before receiving chemotherapy – A systematic review and meta‐analysis
  par: Soe Thiha Maung, et autres
  Publié: (2024)